For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the introduction of Tafamidis and Attruby represents a significant advancement . These innovative therapies preserve the transthyretin protein, preventing its destructive build-up and … Read More